Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

13.8%

4 terminated out of 29 trials

Success Rate

82.6%

-3.9% vs benchmark

Late-Stage Pipeline

10%

3 trials in Phase 3/4

Results Transparency

16%

3 of 19 completed with results

Key Signals

3 with results83% success

Data Visualizations

Phase Distribution

19Total
Not Applicable (11)
Early P 1 (1)
P 2 (4)
P 3 (2)
P 4 (1)

Trial Status

Completed19
Terminated4
Unknown3
Enrolling By Invitation1
Recruiting1
Withdrawn1

Trial Success Rate

82.6%

Benchmark: 86.5%

Based on 19 completed trials

Clinical Trials (29)

Showing 20 of 20 trials
NCT07409194Not ApplicableEnrolling By InvitationPrimary

The Effect of Acupressure on Hyperbilirubinemia in Newborns: A Randomized Controlled Trial

NCT03564678Phase 2Terminated

Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia

NCT07098234Not ApplicableCompletedPrimary

Effect of Vitamin-D as an Adjuvant to Phototherapy in Reduction of Indirect Serum Bilirubin

NCT03195998CompletedPrimary

Validity of Transcutaneous Bilirubin Monitoring in Preterm Infants

NCT06421844Recruiting

A Prospective Study: Smart Phone Application for Measure Serum Bilirubin Through Sclera Images

NCT02712138Withdrawn

Biomarker for Gilbert Disease (BioGilbert)

NCT02691156Completed

Bilirubin Binding Capacity to Assess Bilirubin Load in Preterm Infants

NCT02612207Completed

Point-of-Care System for Determination of Bilirubin Capacity in Neonates

NCT04897113Not ApplicableUnknown

Study of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old

NCT04271098CompletedPrimary

The Investigation of the Causes of Hepatic Dysfunction in the Postoperative Period During Open-heart Surgeries

NCT01622699Not ApplicableCompleted

Implementation of a Transcutaneous Bilirubinometer

NCT02685189TerminatedPrimary

Long-Term Clinical Follow-Up of Children Enrolled in Stannsoporfin Clinical Trial Protocol No. 64,185-06-2(W)

NCT00115544Phase 2CompletedPrimary

Safety and Pharmacology of Stanate

NCT00076960Unknown

Compassionate Use of Stanate (TM) [Stannsoporfin]

NCT02774434Not ApplicableCompletedPrimary

Efficacy Study of the Draeger Jaundice Meter (JM-105) in Neonates of ≥ 24 Weeks of Gestational Age

NCT02446951CompletedPrimary

Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department

NCT00360204Phase 3CompletedPrimary

Improving Health Outcomes for New Mothers and Babies

NCT02613676Not ApplicableCompleted

Transcutaneous Screening for Risk of Severe Hyperbilirubinemia in South African Newborns

NCT02805296Not ApplicableCompletedPrimary

High Intensity Phototherapy: Double vs. Single

NCT01944696Not ApplicableUnknownPrimary

Cycled Phototherapy: A Safer Effective Treatment for Small Premature Infants?

Scroll to load more

Research Network

Activity Timeline